Abstract
The aim of this review is to examine recent advances in experimental and clinical research relevant to the pathogenesis of diarrhea-associated hemolytic uremic syndrome with special reference to histopathologic findings, virulence factors of Shiga toxin-producing Escherichia coli, the host response, and the prothrombotic state. Despite significant advances during the past decade, the exact mechanism by which Shiga toxin-producing E. coli leads to hemolytic uremic syndrome remains unclear. Factors such as Shiga toxin, lipopolysaccharide, the adhesins intimin and E. coli-secreted proteins A, B, and D, the 60-MD plasmid, and enterohemolysin likely contribute to the pathogenesis. Data on the inflammatory response of the host, including leukocytes and inflammatory mediators, are updated. The pathogenesis of the prothrombotic state leading to thrombocytopenia secondary to endothelial cell damage and platelet activation is also discussed. A hypothetical sequence of events from ingestion of the bacteria to the development of full-blown hemolytic uremic syndrome is proposed.
Similar content being viewed by others
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- HUS:
-
hemolytic uremic syndrome
- STEC:
-
Shiga toxin-producing E. coli Stx, Shiga toxin
- D+HUS:
-
diarrhea-associated hemolytic uremic syndrome
- D−HUS:
-
hemolytic uremic syndrome not associated with diarrhea
- EHEC:
-
enterohemorrhagic E. coli EPEC, enteropathogenic E. coli
- Esps:
-
E. coli -secreted proteins
- LPS:
-
lipopolysaccharide
- Gb3:
-
globotriaosylceramide
- TNF-α:
-
tumor necrosis factor-α
References
Gasser C, Gauthier E, Steck A, Siebenmann RE, Oechslin R 1955 Hamolytisch-uramische syndrome: bilaterale nierenrindennekrosen bei akuten erworbenen hamolytischen anamien. Schweiz Med Wochenschr 85: 905–909
Siegler RL 1992 Central nervous system involvement in the hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds). Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. Marcel Dekker, New York, pp 113–129
Rowe PC, Orrbine E, Wells GA, McLaine PN 1991 Epidemiology of hemolytic uremic syndrome in Canadian children from 1986 to 1988. J Pediatr 119: 218–224
van de Kar NC, Roelofs HG, Muytjens HL, Tolboom JJ, Roth B, Proesmans W, Reitsma-Bierens WC, Wolff ED, Karmali MA, Chart H, Monnens LA 1996 Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr 155: 592–595
Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA 1988 Illnesses associated with Escherichia coli O157:H7 infections. Ann Intern Med 109: 705–712
Habib R 1992 Pathology of the hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. Marcel Dekker, New York, pp 315–353
Van Setten PA, Hinsbergh MV, Van Den Heuvel LPWJ, Preyers F, Dijkman HPBM, Assmann KJM, Ven Der Velden TJAM, Monnens LAH 1998 Monocyte chemoattractant protein-1 and interleukin-8 in urine and serum of patients with hemolytic uremic syndrome. Pediatr Res 43: 759–767
Inward CD, Howie AJ, Fitzpatrick MM, Rafaat F, Milford DV, Taylor CM 1997 Renal histopathology in fatal cases of diarrhea-associated haemolytic uraemic syndrome. Pediatr Nephrol 11: 556–559
Karpman D, Hakansson A, Perez MT, Isakson C, Carlemalm E, Caprioli A, Svanborg C 1998 Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66: 636–644
Taguchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, Takeda T, Fujimoto J 1998 Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53: 1681–1688
Griffin PM, Olmstead LC, Petras RE 1990 Escherichia coli O157:H7-associated colitis. Gastroenterology 99: 142–149
Shigematsu H, Dikman SH, Churg J, Grishman E, Duffy JL 1976 Mesangial involvement in hemolytic uremic syndrome. Am J Pathol 85: 349–362
Argyle JC, Hogg RJ, Pysher TJ, Silva FG, Siegler RL 1990 A clinicopathological study of 24 children with hemolytic uremic syndrome: a report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 4: 52–58
Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K 1985 Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38: 469–479
Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML 1983 Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681–685
O'Brien AD, Melton AR, Schmitt CK, McKee ML, Batts ML, Griffin DE 1993 Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol 31: 2799–2801
Besser RE, Lett SM, Weber JT, Doyle MP, Barrett TJ, Wells JG, Griffin PM 1993 An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 269: 2217–2220
Keene WE, McAnulty JM, Hoesly FC, Williams LP, Hedberg K, Oxman GL, Barrett TJ, Pfaller MA, Fleming DW 1994 A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli and Shigella sonnei. N Engl J Med 331: 579–584
Carter AO, Borczyk AA, Carlson JA, Harvey B, Hockin JC, Karmali MA, Krishnan C, Korn DA, Lior H 1987 A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 316: 1496–1500
Krishnan C, Fitzgerald VA, Dakin SJ, Behme RJ 1987 Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. J Clin Microbiol 25: 1043–1047
Emil S, Rockstad R, Vannix D 1998 Hemolytic uremic syndrome in a child with burn injury. J Burn Care Rehabil 19: 135–137
Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H 1985 The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775–782
Schmidt H, Beutin L, Karch H 1995 Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 63: 1055–1061
Brunder W, Schmidt H, Karch H 1997 EspP, a novel extracellular serine protease of enterohemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 24: 767–778
Beutin L, Montengro MA, Ørskov I, Ørskov F, Prada J, Zimmermann S, Stephan R 1989 Close association of verocytotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol 27: 2559–2564
Jarvis KG, Giron JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB 1995 Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci USA 92: 7996–8000
Savarino SJ, McVeigh A, Watson J, Cravioto A, Molina J, Echeverria P, Bhan MK, Levine MM, Fasano A 1996 Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis 173: 1019–1022
Koster F, Levin J, Walker L, Tung KSK, Gilman RH, Rahaman MM, Majid A, Islam S, Williams RC 1978 Hemolytic uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med 298: 927–933
Tschäpe H, Prager R, Streckel W, Fruth A, Tietze E, Böhme G 1995 Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source. Epidemiol Infect 114: 441–450
Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, Karmali M 1987 Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262: 8834–8839
Cohen A, Hannigan GE, Williams BR, Lingwood CA 1987 Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem 262: 17088–17091
Obrig TG, Moran TP, Brown JE 1987 The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244: 287–294
Hurley BP, Jacewicz M, Thorpe M, Lincicome LL, King AJ, Keusch GT, Acheson DWK 1999 Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun 67: 6670–6677
Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson V, Gyles CL 1999 Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497–503
Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM 1998 Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160: 994–998
Scotland SM, Willshaw GA, Smith HR, Rowe B 1987 Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of vero cytotoxins VT1 and VT2. Epidemiol Infect 99: 613–624
Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B 1993 Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in the United Kingdom: 1989–1991. Epidemiol Infect 110: 591–600
Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, Obrien AD, Samuel JE 1993 Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61: 3392–3402
Jacewicz MS, Acheson DWK, Binion DG, West GA, Lincicome LL, Fiocchi C, Keusch GT 1999 Response of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun 67: 1439–1444
Louise CB, Obrig TG 1995 Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172: 1397–1401
Holloway S, Senior D, Roth L, Tisher CC 1993 Hemolytic uremic syndrome in dogs. J Vet Int Med 7: 220–227
Cowan LA, Hertzke DM, Fenwick BW, Andreasen CB 1997 Clinical and clinicopathologic abnormalities in greyhounds with cutaneous and renal glomerular vasculopathy: 18 cases (1992–1994). J Am Vet Med Assoc 210: 789–793
Hertzke DM, Cowan LA, Schoning P, Fenwick BW 1995 Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 32: 451–459
Fenwick BW, Cowan LA 1998 Canine model of haemolytic-uremic syndrome. In: Kaper JB, O'Brien AD (eds) Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. American Society for Microbiology, ASM Press, Washington DC, pp 268–277
Moxley RA 2000 Edema disease. Vet Clin North Am Food Anim Pract 16: 175–185
Parreira VR, Yano T 1998 Cytotoxin produced by Escherchia coli isolated from chickens with swollen head syndrome. Vet Microbiol 62: 111–119
Moxley RA, Francis DH 1998 Overview of animal models. In: Kaper JB, O'Brien AD (eds) Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. American Society for Microbiology, ASM Press, Washington DC, pp 249–260
Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C 1997 The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Inf Dis 175: 611–620
Pai CH, Kelly JK, Meyers GL 1986 Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 51: 16–23
Francis DH, Collins JE, Duimstra JR 1986 Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis. Infect Immun 51: 953–956
Tzipori S, Chow CW, Powell HR 1988 Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J Clin Pathol 41: 1099–1103
Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y 1994 Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H− in mitomycin treated mice. Infect Immun 62: 3447–3453
Wadolkowski EA, Burris JA, O'Brien AD 1990 Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58: 2439–2445
Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD 1990 Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58: 3959–3965
Chae C, Moxley RA, Christopher-Hennings J, Francis DH, Wannemuehler MJ 1994 Shiga-like toxin-II-producing Escherichia coli O157:H7 infection in gnotobiotic piglets: protection against brain vascular lesions with SLT-II antiserum. In: Karmali MA, Goglio AG (eds) Recent Advances in Verocytotoxin Producing Escherichia coli Infections. Elsevier Science, Amsterdam, pp 241–244
Lindgren SW, Melton AR, O'Brien AD 1993 Virulence of enterohemorrhagic Escherichiacoli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 61: 3832–3842
Fontaine A, Arondel J, Sansonetti PJ 1988 Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox-; mutant of Shigella dysenteriae 1. Infect Immun 56: 3099–3109
Zoja C, Corna D, Farina C, Sacchi G, Lingwood C, Doyle MP, Padhye VV, Abbate M, Remuzzi G 1992 Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med 120: 229–238
Lingwood CA 1994 Verotoxin binding in human renal sections. Nephron 66: 21–28
Boyd B, Lingwood C 1989 Verotoxin receptor glycolipid in human renal tissue. Nephron 51: 207–210
Ren J, Utsunomiya I, Tagushi K, Ariga T, Tai T, Ihara Y, Miyatake T 1999 Localization of verotoxin receptors in nervous system. Brain Res 825: 183–188
Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA 1992 Experimental verocytotoxemia in rabbits. Infect Immun 60: 4154–4167
Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD 1986 Morphologic evaluation of the effects of Shiga toxin and Escherichia coli Shiga-like toxin on the rabbit intestine. Am J Pathol 125: 69–80
Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B 1993 A reporter transgene indicates renal-specific induction of tumor necrosis factor by Shiga-like toxin. J Clin Invest 92: 2110–2116
Taylor FB, Tesh VL, DeBault L, Li A, Chang ACK, Kosanke SD, Pysher TJ, Siegler RL 1999 Characterization of the baboon responses to Shiga-like toxin. Am J Pathol 154: 1285–1298
Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW 1988 Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56: 2373–2378
Louise CB, Obrig TG 1991 Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1B, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59: 4173–4179
Louise CB, Obrig TG 1992 Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60: 1536–1543
Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien AD 1991 Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164: 344–352
Keusch GT, Acheson DWK, Aaldering L, Erban J, Jacewicz MS 1996 Comparison of the effects of Shiga-like toxin I on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis 173: 1164–1170
Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney B, Daniel TO 1993 Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268: 15484–15488
Yoshida T, Fukada M, Koide N, Ikeda H, Sugiyama T, Kato Y, Ishikawa N, Yokochi T 1999 Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J Infect Dis 180: 2048–2052
van de Kar NCAJ, Monnens LAH, Karmali MA, van Hinsbergh VWM 1992 Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80: 2755–2764
Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG 1993 Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells In Vitro. Infect Immun 61: 3886–3891
Louise CB, Kaye SA, Boyd B, Lingwood CA, Obrig TG 1995 Shiga-toxin associated hemolytic-uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect Immun 63: 2766–2769
Bitzan MA, Wang Y, Lin J, Marsden PA 1998 Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 101: 372–382
Yuhas Y, Kaminsky E, Mor M, Ashkenazi S 1996 Induction of nitric oxide production in mouse macrophages by Shiga toxin. J Med Microbiol 45: 97–102
Hughes AK, Stricklett PK, Schmid D, Kohan DE 2000 Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57: 2350–2359
Hughes AK, Stricklett PK, Kohan DE 1998 Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54: 426–437
Waddell T, Cohen A, Lingwood CA 1990 Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriaosylceramide. Proc Natl Acad Sci USA 87: 7898–7901
Kiyokawa N, Taguchi T, Mori T, Uchida H, Sato N, Takeda T, Fujimoto J 1998 Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis 178: 178–184
Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J 1993 Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 53: 5314–5319
Jones NL, Islur A, Haq R, Mascarenhas M, Karmali MA, Perdue MH, Zanke BW, Sherman PM 2000 Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol 278: G811–G819
Uchida H, Kiyokawa N, Taguchi T, Horie H, Fujimoto J, Takeda T 1999 Shiga toxins induce apoptosis in pulmonary epithelium-derived cells. J Infect Dis 180: 1902–1911
Inward CD, Williams J, Chant I, Crocker J, Milford DV, Rose PE, Taylor CM 1995 Verocytotoxin-1 induces apoptosis in vero cells. J Infect 30: 213–218
Lieberthal W, Levine JS 1996 Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271: F477–F488
Savill J, Mooney A, Hughes J 1996 Apoptosis and renal scarring. Kidney Int Suppl 54: S14–S17
Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z 1996 Apoptosis in glomerular sclerosis. Kidney Int 49: 103–111
Philpott DJ, Ackerley CA, Kiliaan AJ, Karmali MA, Perdue MH, Sherman PM 1997 Translocation of verotoxin 1 across T84 monolayers: mechanisms of bacterial toxin penetration of epithelium. Am J Physiol 273: G1349–G1358
Coratelli P, Buongiorno E, Passavanti G 1988 Endotoxemia in hemolytic uremic syndrome. Nephron 50: 365–367
Bitzan M, Moebius E, Ludwig K, Mueller-Wiefel DE, Heesemann J, Karch H 1991 High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic uremic syndrome. J Pediatr 119: 380–385
Proulx F, Seidman E, Mariscalco MM, Lee K, Caroll SF 1999 Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome. Clin Diagn Lab Immunol 6: 773
Bertani T, Abbate M, Zoja C, Corna D, Remuzzi G 1989 Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome. Nephron 53: 330–337
Butler T, Rahman H, Al-Mahmud KA, Islam M, Bardhan P, Kabir I, Rahman MM 1985 An animal model of haemolytic-uraemic syndrome in shigellosis: lipopolysaccharides of Shigella dysenteriae I and S. flexneri produce leukocyte-mediated renal cortical necrosis in rabbits. Br J Exp Pathol 66: 7–15
Barrett TJ, Potter ME, Wachsmuth IK 1989 Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 57: 3434–3437
Barrett TJ, Potter ME, Strockbine NA 1990 Evidence for participation of the macrophage in Shiga-like toxin II induced lethality in mice. Microbiol Pathog 9: 95–103
Palermo M, Alves-Rosa F, Rubel C, Fernandez GC, Fernadez-Alonso G, Alberto F, Rivas M, Isturiz M 2000 Pretreatment of mice with lipopolysaccharide (LPS) or IL-1B exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119: 77–83
Paton AW, Voss E, Manning PA, Paton JC 1998 Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial cells. Microb Pathog 24: 57–63
Phillips AD, Navabpour S, Hicks S, Dougan G, Wallis T, Frankel G 2000 Enterohemorrhagic Escherichia coli O157:H7 target Peyers patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 47: 377–381
Dytoc M, Soni R, Cockerill F, De Azavedo J, Louie M, Brunton J, Sherman P 1993 Multiple determinants of verotoxin-producing Escherichia coli O157:H7 attachment-effacement. Infect Immun 61: 3382–3391
Moon HW, Whipp SC, Argenzio RA, Levine MM, Gianella RA 1983 Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun 41: 1340–1351
Knutton S, Baldwin T, Williams PH, McNeish AS 1989 Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 57: 1290–1298
Jerse AE, Yu J, Tall BD, Kaper JB 1990 A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87: 7837–7843
Jerse AE, Kaper JB 1991 The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect Immun 59: 4302–4309
Jarvis KG, Kaper JB 1996 Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect Immun 64: 4826–4829
Kenny B, DeVinney R, Stein M, Reinsceid DJ, Frey EA, Finlay BB 1997 Enteropathogenic E. coli transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511–520
Deibel C, Kramer S, Chakraborty T, Ebel F 1998 EspE, a novel secreted protein of attaching and effacing bacteria, is directly translocated into infected host cells, where it appears as a tyrosine-phosphorylated 90 kDa protein. Mol Microbiol 28: 463–474
Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S 1998 Enteropathogenic and enterohemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 30: 911–921
Sperandio V, Mellies JL, Nguyen W, Shin S, Kaper JB 1999 Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 96: 15196–15201
Levine MM, Xu J, Kaper JB, Lior H, Prado V, Tall B, Nataro J, Karch H, Wachsmuth K 1987 A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 156: 175–182
Barrett TJ, Kaper JB, Jerse AE, Wachsmuth IK 1992 Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J Infect Dis 165: 979–980
Karch H, Heesemann J, Laufs R, O'Brien AD, Tacket CO, Levine MM 1987 A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun 55: 455–461
Toth I, Cohen ML, Rumschlag HS, Riley LW, White EH, Carr JH, Bond WW, Wachsmuth IK 1990 Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun 58: 1223–1231
Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E 2000 Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic uremic syndrome. Pediatr Infect Dis J 19: 642–647
Salzman MB, Ettenger RB, Cherry JD 1991 Leukocytosis in hemolytic uremic syndrome. Pediatr Infect Dis J 10: 470–471
Bell P, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI 1997 Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100: 127(http://www.pediatrics.org/e12)
Wong CS, Jelacic S, Habeeb RL, Watkins S, Tarr PI 2000 The risk of the hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 26: 1930–1936
Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT 1990 The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 323: 1161–1167
Walters MD, Matthei IE, Kay R, Dillon MJ, Barratt TM 1989 The polymorphonuclear leukocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3: 130–134
Coad NA, Marshall T, Rowe B, Taylor CM 1991 Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35: 10–16
Milford D, Taylor CM, Rafaat F, Halloran H, Dawes J 1989 Neutrophil elastases and haemolytic uraemic syndrome. Lancet 2: 1153
Forsyth KD, Simpson AC, Fitzpatrick MM, Barratt TM, Levinsky RJ 1989 Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome. Lancet 2: 411–414
Hughes DA, Smith GC, Davidson JE, Murphy AV, Beattie TJ 1996 The neutrophil oxidative burst in diarrhea-associated haemolytic uraemic syndrome. Pediatr Nephrol 10: 445–447
Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM 1992 Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42: 951–956
Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM 1992 Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 6: 50–53
Vierzig A, Roth B, Querfeld U, Michalk D 1998 A 12-year-old boy with fatal hemolytic uremic syndrome, excessive neutrophilia and elevated endogenous granulocyte-colony-stimulating-factor serum concentrations. Clin Nephrol 50: 56–59
Fernandez GC, Rubel C, Dran G, Gomez S, Isturiz MA, Palermo MS 2000 Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome. Clin Immunol 95: 227–234
Morigi M, Micheletti G, Figliuzzi M, Imberti B, Karmali MA, Remuzzi A, Remuzzi G, Zoja C 1995 Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86: 4553–4558
Te Loo, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW 2000 Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95: 3396–3402
King AJ, Sundaram S, Cendoroglo M, Acheson DW, Keusch GT 1999 Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. J Infect Dis 179: 503–507
Palermo MS, Alver Rosa MF, Van Rooijen N, Isturiz MA 1999 Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol 116: 462–467
Van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW 1996 Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis and induction of cytokine release. Blood 88: 174–183
Sakiri R, Ramegowda B, Tesh VL 1998 Shiga toxin 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kappa B and activator protein-1. Blood 92: 558–566
Foster GH, Armstrong CS, Sakiri R, Tesh VL 2000 Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinase. Infect Immun 68: 5183–5189
Proulx F, Litalien C, Turgeon JP, Mariscalco MM, Seidman E 1998 Inflammatory mediators in hemorrhagic colitis and hemolytic uremic syndrome. Pediatr Inf Dis 17: 899–904
Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E 2000 Circulating inflammatory cytokine levels predict severity of renal failure in hemolytic uremic syndrome. Pediatr Nephrol 35: 28–34
Van de Kar NCAJ, Sauerwein RW, Demacker PNM, Grau GE, Van Hinsbergh VWM, Monnens LAH 1995 Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71: 309–313
Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C 1995 Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 9: 694–699
Proulx F, Dugas MA, Litalien C, Seidman E 2000 Circulating levels of transforming growth factor beta 1 and lymphokines in children with hemolytic uremic syndrome. Am J Kidney Dis 35: 1–7
Yamamoto T, Isokawa S, Miyata H, Yoshioka K 1999 Evaluation of thrombomodulin and tumor necrosis factor-alpha levels in patients with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection. Nippon Jinzo Gakkai Shi 41: 60–64
Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM 1997 Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child 77: 145–147
Inward CD, Pall AA, Adu D, Milford DV, Taylor CM 1995 Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome. Pediatr Nephrol 9: 574–578
Murata A, Shimazu T, Yamamoto T, Taenaka N, Nagayama K, Honda T, Sugimoto H, Monden M, Matsura N, Okada S 1998 Profiles of circulating inflammatory and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E. coli O157 infection. Cytokine 10: 544–548
Yamamoto T, Nagayama K, Satomura K, Honda T, Okada S 2000 Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157. Nephron 84: 326–332
Lopez EL, Contrini MM, Devoto S 1995 Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr Infect Dis J 14: 594–598
Nevard CHF, Blann AD, Jurd KM, Haycock GB, Hunt B 1999 Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome. Pediatr Nephrol 13: 487–492
Kohan DE, Padilla EC, Sielger RL 1994 Endothelin concentration and endothelin stimulating activity in the plasma of children with post-diarrheal hemolytic uremic syndrome. In: Karmali MA, Goglio AG (eds) Recent Advances in Verocytotoxin-Producing Escherichia coli Infections. Elsevier, Amsterdam, pp 377–379
Masri C, Proulx F, Toledano B, Clermont MJ, Mariscalco MM, Seidman E, Carcillo J 2000 Soluble Fas and soluble Fas-L in children with Escherichia coli O157:H7 infections. Am J Kidney Dis 36: 687–694
Chiu PJS, Radwanski E, Tetiloff G, Monge A, Swanson SJ 1996 Interleukin-10 pharmacokinetics in intact and nephrectomized mice. Eur Cytokine Netw 7: 67–69
Akira S, Hirano T, Taga T, Kishimoto T 1990 Biology of multifunctional cytokines: IL-6 and related molecules: IL-1, TNF. FASEB J 4: 2860–2867
Ohta K, Takano N, Seno A, Yachie A, Miyawaki T, Yokoyama H, Tomosugi N, Kato E, Taniguchi N 1992 Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. Clin Nephrol 38: 185–189
Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DW 1999 Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun 67: 5985–5993
Yamasaki C, Natori Y, Zeng XT, Ohmura M, Yamasaki S, Takeda Y, Natori Y 1999 Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 and 2 but not by non-toxic mutant Stx 1 which lacks N-glycosidase activity. FEBS Lett 442: 231–234
Isogai E, Isogai H, Kimura K, Hayashi S, Kubota T, Fujii N, Takeshi K 1998 Role of tumor necrosis factor alpha in gnotobiotic mice infected with Escherichia coli O157:H7 strain. Infect Immun 66: 197–202
Hughes AK, Stricklett PK, Kohan DE 1998 Shiga toxin-1 regulation of cytokine production by human proximal tubule cells. Kidney Int 54: 1093–1106
Ray PE, Liu XH, Xu L, Rakusan T 1999 Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome. Pediatr Nephrol 13: 586–593
Benigni A, Boccardo P, Noris M, Remuzzi G, Siegler RL 1992 Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome. Lancet 339: 835–836
Katz AI, Emmanouel DS 1978 Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 22: 69–80
Mattyus I, Zimmerhackl LB, Schwartz A, Brabdis M, Milteyi M, Tulassay T 1997 Renal excretion of endothelin in children. Pediatr Nephrol 11: 513–521
Siegler RL, Edwin SS, Christofferson RD, Mitchell MD 1991 Endothelin in the urine of children with the hemolytic uremic syndrome. Pediatrics 88: 1063–1066
Fong JS, Kaplan BS 1982 Impairment of platelet aggregation in hemolytic uremic syndrome. Blood 60: 564–570
Sassetti B, Vizcargüénaga MI, Zanaro NL, Silva MV, Kordich L, Florentini L, Diaz M, Vitacco M, Sanchez Avalos JC 1999 Hemolytic uremic syndrome in children: platelet aggregation and membrane glycoproteins. J Pediatr Hematol Oncol 21: 123–128
Galli M, Grassi A, Barbui T 1996 Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost 75: 427–431
Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM 1988 Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 33: 107–115
Appiani AC, Edefonti A, Bettinelli A, Cossu MM, Paracchini ML, Rossi E 1982 The relationship between plasma levels of the factor VIII complex and platelet release products B-thromboglobulin and platelet factor 4 in children with the haemolytic uraemic syndrome. Clin Nephrol 17: 195–199
Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y 1993 Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 84: 702–710
Cooling LLW, Walker KE, Gille T, Koerner TAW 1998 Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun 66: 4355–4366
Rose PE, Armour JA, Williams CE, Hill F 1985 Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol 38: 438–441
Yoshimura K, Fujii J, Yutsudo T, Kikuchi R, Soejima T, Shirahata S, Yoshida S 1998 No direct effects of Shiga toxin 1 and 2 on the aggregation of human platelets in vitro. Thromb Haemost 80: 529–530
Thorpe CM, Flaumenhaft R, Hurley B, Jacewicz M, Acheson DWK, Keusch GT 1999 Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets. Acta Haematol 102: 51–55
Viisoreanu D, Polanowska-Grabowska R, Suttitanamongkol S, Obrig TG, Gear AR 2000 Human platelet aggregation is not altered by Shiga toxin 1 or 2. Thromb Res 98: 403–410
Karpman D, Papadopoulou D, Nilsson K, Sjögren A-C, Mikaelsson C, Lethagen S 2001 Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 97: 3100–3108
van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA 1994 The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. Pediatr Res 36: 257–264
Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MB 1978 Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?. Lancet 2: 871–872
Alam AN, Abdal NM, Wahed MA, Rao B, Kawser CA, Hoque M, Rahaman MM 1991 Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children. Arch Dis Child 66: 1231–1234
Tonshoff B, Momper R, Kuhl PG, Schweer H, Scharer K, Seyberth HW 1990 Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney Int 37: 1134–1141
Zoja C, Remuzzi G 1992 The pivotal role of the endothelial cell in the pathogenesis of HUS. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. Marcel Dekker, New York, pp 389–404
Turi S, Nemeth I, Vargha I, Matkovics B 1994 Oxidative damage of red blood cells in haemolytic uraemic syndrome. Pediatr Nephrol 8: 26–29
Uchida H, Kiyokawa N, Horie H, Fujimoto J, Takeda T 1999 The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 45: 133–137
Ostroff SM, Kobayashi JM, Lewis JH 1989 Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance. JAMA 262: 355–359
Newburg DS, Chaturvedi P, Lopez EL, Devoto S, Fayad A, Cleary TG 1993 Susceptibility to haemolytic-uraemic syndrome relates to erythrocyte glycosphingolipid patterns. J Infect Dis 168: 476–479
Taylor CM, Milford DV, Rose PE, Roy TCF, Rowe B 1990 The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome. Pediatr Nephrol 4: 59–61
Perna NT, Plunkett G, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharam TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR 2001 Genome sequence of enterohemorrhagic Escherichia coli O157:H7. Nature 409: 529–533
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Proulx, F., Seidman, E. & Karpman, D. Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Pediatr Res 50, 163–171 (2001). https://doi.org/10.1203/00006450-200108000-00002
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-200108000-00002
This article is cited by
-
A bacterial autotransporter impairs innate immune responses by targeting the transcription factor TFE3
Nature Communications (2023)
-
TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease
Thrombosis Journal (2018)
-
Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children
European Journal of Clinical Microbiology & Infectious Diseases (2017)
-
Hemolytic uremic syndrome caused by E. coli O157 infection
Forensic Science, Medicine, and Pathology (2017)
-
Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome
Pediatric Nephrology (2012)
